Immunotec Earns Two Gold Globee® Awards, Including Best of Category Honors for Global Growth and Immunocal® Innovation

International recognition celebrates Immunotec’s exceptional business performance and three decades of scientific innovation.

HOUSTON, TX, UNITED STATES, November 10, 2026 /EINPresswire.com/ — Immunotec, a global health and wellness company with nearly three decades of experience advancing glutathione science and a portfolio of 81 patents, has earned two prestigious Gold Globee^® Awards in the 16th Annual 2026 Globee^® Awards for Business, a globally recognized awards program honoring excellence in business, innovation and leadership. Both distinctions also received Best of Category honors, recognizing the company’s achievements in business growth and life sciences innovation.

Immunotec was recognized in two categories:
Achievement in Rapid Growth & Scaling — Gold Globee^® Winner, Best of Category: Recognizing Immunotec’s ability to accelerate global growth while strengthening profitability and its existing business.

HealthTech, Life Sciences or Biotech Product or Service of the Year — Gold Globee^® Winner, Best of Category: Honoring Immunocal^®, Immunotec’s flagship product, for three decades of innovation and contributions to life sciences research.

The dual recognition highlights two defining strengths of Immunotec: its ability to build a stronger, more scalable global business and its longstanding commitment to advancing scientific research and product innovation.

“These two awards represent something we’re incredibly proud of: our ability to grow as a global business while staying true to the science that has defined Immunotec for nearly three decades,” said Mauricio Domenzain, Chief Executive Officer of Immunotec. “Our success has never been about growth alone. It’s about building a stronger company, continuing to advance the research behind Immunocal and creating lasting value for the people and communities we serve. This recognition is a testament to the dedication of our entire global team and the independent Consultants who help bring our mission to life every day.”

Accelerating Global Growth While Strengthening Profitability
Immunotec’s Gold Globee^® Award for Achievement in Rapid Growth & Scaling recognizes a period of significant business transformation, during which the company expanded its global reach while improving financial performance and reinforcing its core operations.

Under a disciplined growth strategy, Immunotec increased annual revenue from approximately $145 million in 2023 to $200 million in 2025. During that same period, EBITDA grew from approximately $10 million to nearly $25 million, demonstrating the company’s ability to translate revenue growth into stronger profitability.

These results reflect a deliberate focus on sustainable expansion, operational efficiency and long-term financial strength rather than growth at any cost.

Today, Immunotec operates in 31 markets worldwide across North America, Latin America and Europe, with a recent expansion into Asia. Supported by a growing international community of customers and independent consultants, the company continues to strengthen its global presence and financial foundation, positioning it to pursue new opportunities while investing in the continued growth of its established markets.

Immunocal^®: Three Decades of Science-Driven Innovation
Immunotec’s second Gold Globee^® Award recognizes Immunocal^®, its flagship product, in the HealthTech, Life Sciences or Biotech Product or Service of the Year category.

For approximately 30 years, Immunocal has been at the center of Immunotec’s scientific mission, supported by ongoing research into cysteine delivery, glutathione production and cellular health.

Its scientific foundation is supported by a substantial body of research, including more than 90 scientific publications and 26 blinded human clinical trials. Immunotec has also continued to advance its intellectual property portfolio through research and patented innovations involving Immunocal and related scientific applications.

The award recognizes not only Immunocal’s longevity but also the continued scientific investment and innovation behind a product that has remained central to Immunotec’s mission for three decades. Beyond its research legacy, Immunocal has established a significant global presence, contributing to Immunotec’s delivery of more than 10 million boxes of Immunocal to customers worldwide over the past five years.

A Shared Commitment to Science and Sustainable Growth
Together, the two Gold Globee^® Awards reflect Immunotec’s approach to building a company where scientific innovation and business performance reinforce one another.

As Immunotec continues to expand its international presence, the company remains focused on strengthening its operations, supporting its global community and investing in research that advances its product portfolio.

The Globee^® Awards for Business recognize organizations, products, teams and individuals demonstrating excellence and achievement across industries worldwide.

About Immunotec
Immunotec is a global health and wellness company dedicated to helping people live healthier, more fulfilling lives through science-backed nutritional products and an entrepreneurial business opportunity. Its flagship product, Immunocal^®, is a proprietary cysteine-rich whey protein isolate developed to support the body’s natural production of glutathione. Backed by decades of scientific research, Immunotec serves customers and independent Consultants across 31 global markets. For more information about Immunotec and Immunocal, visit www.immunotec.com.

About the Globee^® Awards
The Globee^® Awards are an international business awards program recognizing outstanding achievements in business, innovation, leadership, products and services. The annual Globee^® Awards for Business honor organizations and individuals demonstrating excellence across a wide range of industries and disciplines.

Axel Herrera
Immunotec
+52 56 6228 0249
aherrera@immunotec.com

Media gallery